Mitochondrial function is challenged by toxic by-products of metabolism as well as by pathogen attack 1, 2 . Caenorhabditis elegans normally responds to mitochondrial dysfunction with activation of mitochondrial-repair, drug-detoxification and pathogen-response pathways [1] [2] [3] [4] [5] [6] [7] . Here, from a genome-wide RNA interference (RNAi) screen, we identified 45 C. elegans genes that are required to upregulate detoxification, pathogen-response and mitochondrial-repair pathways after inhibition of mitochondrial function by drug-induced or genetic disruption. Animals defective in ceramide biosynthesis are deficient in mitochondrial surveillance, and addition of particular ceramides can rescue the surveillance defects. Ceramide can also rescue the mitochondrial surveillance defects of other gene inactivations, mapping these gene activities upstream of ceramide. Inhibition of the mevalonate pathway, either by RNAi or statin drugs, also disrupts mitochondrial surveillance. Growth of C. elegans with a significant fraction of bacterial species from their natural habitat causes mitochondrial dysfunction. Other bacterial species inhibit C. elegans defence responses to a mitochondrial toxin, revealing bacterial countermeasures to animal defence.
Mitochondria are almost entirely composed of proteins encoded by the nuclear genome 8 . A surveillance pathway detects mitochondrial defects to induce mitochondrial chaperone genes hsp-6 and hsp-60 and xenobiotic-detoxification and pathogen-response pathways [1] [2] [3] [4] [5] [6] [7] . Disrupting C. elegans mitochondrial function induces drug-detoxification genes such as cyp-14A3 and ugt-61 ( Fig. 1a-c) , as well as a Pseudomonas pathogenresponse gene irg-1 (ref. 9) ( Fig. 1d ). This suggests that animals interpret a disruption of mitochondrial activity as a xenobiotic or pathogen attack. Consistent with this, C. elegans exhibits bacterial-avoidance behaviour when mitochondria are inhibited by RNAi or antimycin, an inhibitor of mitochondrial electron transport produced by Streptomyces 1 (Fig. 1e, f ). Animals also show aversive behaviours in the absence of any drug or mitochondrial gene inactivation if they carry a mutation of the nuclearly encoded mitochondrial gene isp-1(qm150) (Fig. 1g ). This mutation also activates hsp-6 ( Fig. 1h ).
C. elegans live in microbe-rich environments 10 . We isolated microbes from habitats with wild C. elegans populations 10 , classified them based on their 16S ribosomal sequences (B.S.S., M. A. Félix & G.R., unpublished observations), and found that 18% of the 560 strains tested caused mitochondrial stress as revealed by induction of hsp-6p::gfp (where p indicates promoter and gfp indicates the gene encoding green fluorescent protein) ( Fig. 2a-c ). This suggests that mitochondria are targeted by many bacterial species, and explains the evolutionary advantage of coupling detection of C. elegans mitochondrial dysfunction to antibacterial gene expression and behavioural responses. Iron is a valuable resource to microbes, which often produce siderophores to capture the iron; the eukaryotic mitochondrion, rich in haem and iron sulphur proteins, is an attractive iron depot for bacteria. Bacterial toxins, siderophores or virulence factors from these many bacterial strains may target the mitochondrion.
To identify the molecular basis behind the detection of animal mitochondrial dysfunction and its coupling to a detoxification response, we performed a genome-wide RNAi screen for gene inactivations that render C. elegans unresponsive to mitochondrial dysfunction (Extended Data Figs 1 and 2). Gene inactivations that caused a failure to induce hsp-6p::gfp in antimycin were re-screened for failure to upregulate other genes normally induced by mitochondrial dysfunction: the detoxification gene ugt-61::gfp in the presence of antimycin, hsp-6p::gfp induction in the isp-1(qm150) mutant, or hsp-6p::gfp induction in response to RNAi targeting the ATP synthase atp-2. Mitochondrial surveillance and response was disrupted by 45 gene inactivations (Extended Data Table 1), including the known components atfs-1, clpp-1 and dve-1 (refs 4, 6) .
One of the gene inactivations that potently disrupts response to mitochondrial dysfunction, sptl-1, encodes serine palmitoyltransferase, which has a role in the sphingolipid biosynthesis pathway (Extended Data Fig. 3 ). Inactivation of sptl-1 by RNAi inhibited the induction of hsp-6p::gfp upon antimycin treatment or spg-7(RNAi) (Fig. 3a, b ), whereas sptl-1(RNAi) alone without antimycin treatment did not induce the expression of hsp-6p::gfp (Extended Data Fig. 4b ). sptl-1(RNAi) did not affect the activation of endoplasmic reticulum stress reporter hsp-4p::gfp by the drug tunicamycin ( Fig. 3c ), indicating a specific role in mitochondrial surveillance. A probable null mutation in sptl-1 (Extended Data Fig. 5a ) impaired the induction of hsp-6, cyp-14A3 and ugt-61 after mitochondrial disruption by spg-7(RNAi) (Fig. 3d ). A double mutant in the two ceramide synthase genes of the sphingolipid biosynthetic pathway also attenuated the induction of hsp-6 upon mitochondrial damage (Extended Data Fig. 5b ). Treatment with myriocin, a fungal inhibitor of mammalian serine palmitoyltransferase, disrupted antimycininduced hsp-6p::gfp induction ( Fig. 3e ). sptl-1(RNAi) (with normal movement, Supplementary Videos 1 and 2) attenuated food avoidance induced by antimycin or spg-7(RNAi), suggesting that this behavioural response is also coupled to sptl-1 ( Fig. 3g and Extended Data Fig. 4d, e ). sptl-1 expression is upregulated 2.5-fold by mitochondrial damage (Extended Data Fig. 4a ), suggesting that increased sphingolipid levels during mitochondrial disruption may act as a signal rather than as a membrane component required for another signal.
The morphology of the normally extensive mitochondrial network of C. elegans and other animals is responsive to mutation or inactivation of mitochondrial components 11 . Mitochondria in sptl-1(RNAi) animals hyperfused into larger, longer mitochondria ( Fig. 3f ), suggesting that sptl-1 is critical for mitochondrial homeostasis. The isp-1 mitochondrial mutant had a severe synthetic growth defect on a sptl-1(RNAi) background, whereas wild-type development was only slightly delayed on sptl-1(RNAi) (Fig. 3h ). Sphingolipid signalling may act in the homeostatic response to the mitochondrial defect caused by the isp-1(qm150) mutation; in the absence of that response, isp-1(qm150) may cause a more severe mitochondrial defect and growth arrest. sptl-1(RNAi) animals were also more sensitive to the mitochondrial inhibitor antimycin (Extended Data Fig. 4f ). In addition, sptl-1(RNAi) animals were unable to sense mitochondrial inhibition and activate the mitochondrial surveillance pathway when challenged by a set of the wild microbes that disrupt mitochondrial function (Extended Data Fig. 4g ).
Ceramide supplementation rescued the sptl-1 defect in mitochondrial surveillance ( Fig. 4a and Extended Data Fig. 5d ), whereas ceramide in the absence of mitochondrial damage did not induce hsp-6p::gfp (Extended Data Fig. 5e ), suggesting that ceramide is not a sufficient signal to induce the suite of responses to mitochondrial dysfunction in the absence of true mitochondrial dysfunction. Ceramide supplementation also partially rescued the mitochondrial morphology defect ( Fig. 4b ) and the impaired food-avoidance behaviour caused by sptl-1(RNAi) (Extended Data Fig. 6a ). Dihydroceramide, a ceramide precursor with no signalling function in mammals, could not rescue the sptl-1(RNAi) mitochondrial surveillance defect ( Fig. 4a ). Two C. elegans ceramide synthases, HYL-1 and HYL-2, synthesize different ceramide species (C24 to C26 and C20 to C22, respectively 12 ). On testing C16, C20, C22 and C24 ceramides, only C24 rescued the deficiency of mitochondrial surveillance caused by sptl-1(RNAi) (Fig. 4c) .
During apoptosis and mitophagy, ceramide accumulates on the outer membrane of mitochondria [13] [14] [15] . Using antibodies to stain ceramide and Complex IV (COX-IV; a mitochondrial protein in the electron transport chain), ceramide and mitochondrial protein colocalization was shown to markedly increase after C. elegans mitochondrial inhibition ( Fig. 4d ). a Induction of hsp-6p::gfp by wild microbes 0% 25% 50% 75%
Pseudomonas (106) Enterobacteriaceae (103) Stenotrophomonas (17) Sphingobacterium (13) Chryseobacterium (6) Per cent of bacteria genera tested Non-activating 82% Figure 2 | Some bacterial species from the C. elegans natural habitat antagonize the mitochondria. a, Genera that induce hsp-6p::gfp (100 of 560 tested microbes (18%)). b, Proportion of bacterial genera tested that cause mitochondrial dysfunction and hsp-6p::gfp induction. c, hsp-6p::gfp animals raised on E. coli or natural microbial species. d, Six bacterial strains that render C. elegans defective in hsp-6 response to antimycin. e, hsp-6p::gfp animals exposed to antimycin and raised on control E. coli or the six microbial strains.
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The increased colocalization preceded induction of hsp-6p::gfp (Extended Data Fig. 6b , c). Thus, ceramide may participate in an early step of mitochondrial surveillance by marking domains of dysfunction.
To map ceramide relative to other gene inactivations that render animals unable to respond to mitochondrial damage, we tested whether ceramide could rescue the mitochondrial surveillance defects of other hits from the RNAi screen. Five other gene inactivations were rescued by ceramide: ran-4, a nuclear transport component; Y47G6A.29, a phosphatidylinositol signalling component; F40F12.7, a zinc finger protein; Y54E10BR.5, a signal peptidase component; and ceh-20, a homeobox transcription factor (Extended Data Fig. 6e ). These gene inactivations may disrupt mitochondrial surveillance upstream of ceramide production.
ATFS-1 is a transcription factor that activates hsp-6 and hsp-60 during mitochondrial stress ( Fig. 4e ) 5 . ATFS-1 contains an amino-terminal mitochondrial targeting sequence as well as a carboxy-terminal nuclear localization signal; when mitochondria are damaged, nuclear accumulation of ATFS-1 is favoured 6 . Deletion of the N-terminal 1-32 amino acids causes constitutive nuclear accumulation of ATFS-1 (Extended Data Fig. 6d ) and activates hsp-60p::gfp 6 . Activation of hsp-60p::gfp by ATFS-1 D1-32.myc did not require sptl-1 gene activity ( Fig. 4f ), suggesting that ceramide works upstream of ATFS-1 and has a role in the early detection of mitochondrial dysfunction.
hmgs-1, which encodes an HMG-CoA (3-hydroxy-3-methyl-glutarylcoenzyme A) synthase of the mevalonate synthetic pathway, is also a strong hit from the genome-wide screen. hmgs-1 gene inactivation inhibited antimycin-induced hsp-6p::gfp induction and food avoidance (Extended Data Fig. 7a-d) . hmgs-1(RNAi) also induced abnormal mitochondrial morphology (Extended Data Fig. 7e ). Supplementing mevalonate to hmgs-1(RNAi) animals rescued the deficiency of antimycininduced hsp-6p::gfp (Extended Data Fig. 7f ).
Statins are cholesterol-lowering drugs that inhibit the mevalonate pathway (Extended Data Fig. 8a) 16 . Treating C. elegans with statins also abrogates their ability to sense mitochondrial damage and activate protective programs (Extended Data Figs 7g and 8b) . A common side effect of statin therapy is muscle toxicity 17 . By inhibiting the mevalonate pathway, statins inhibit ubiquinone synthesis, a key component of the electron transport chain (Extended Data Fig. 8a ). Our data suggest that a combined inhibition of ubiquinone synthesis and mitochondrial surveillance may contribute to the muscle toxicity of statins. In support of a role for mitochondrial surveillance in statin action, a gain-of-function mutation in C. elegans atfs-1 confers statin resistance 18 . Treating human embryonic kidney HEK293T cells with statin impaired the mitochondrial network and morphology (Extended Data Figs 7h and 9 ). Statin treatment also decreased ATP production in mouse C2C12 myotubes (Extended Data Fig. 7i ).
Eukaryotic mitochondrial surveillance pathway components are likely to be targets of microbial toxins and virulence factors. If the mitochondrial surveillance pathway in an animal is disabled by a bacterial toxin or virulence factor, other anti-mitochondrial toxins, siderophores or virulence factors would be rendered more effective. To detect such bacterial anti-surveillance activities, we screened our collection of C. elegans flora for bacterial species that, when co-cultured with C. elegans, could disrupt the induction of hsp-6p::gfp by antimycin. Six wild bacterial strains of the genus Pseudomonas from three species (vranovensis, brenneri is required for mitochondrial surveillance. a, hsp-6p::gfp animals raised on control or sptl-1(RNAi) in the presence or absence of antimycin. b, GFP immunoblot expressed by hsp-6p::gfp animals in the presence or absence of antimycin or spg-7(RNAi). c, hsp-4p::gfp animals raised on control or sptl-1(RNAi) in the presence or absence of the endoplasmic reticulum drug tunicamycin. d, C. elegans hsp-6 and xenobiotic-detoxification gene transcripts in control or sptl-1(ok1693) mutant animals after exposure to spg-7(RNAi) (n 5 2). e, hsp-6p::gfp animals raised in the presence or absence of myriocin. f, Body wall muscle of sptl-1(RNAi) compared to wild-type animals expressing a mitochondrially localized GFP reporter. g, Food-avoidance phenotypes for control or sptl-1(RNAi) animals treated with antimycin. h, Wild type (N2) or isp-1(qm150) raised on control or sptl-1(RNAi).
RESEARCH LETTER
and asplenii) disrupt mitochondrial surveillance ( Fig. 2d, e ). The dozens of C. elegans genes we have identified in the mitochondrial surveillance pathway are candidate targets for toxins or virulence factors from these Pseudomonas strains.
Our studies have revealed roles of ceramide and mevalonate in mitochondrial surveillance. The products of these pathways either constitute signals that are transferred within or between cells, or structures within those cells that are necessary for other signals to emerge. We favour that these constitute signals because the expression of these biosynthetic pathways are induced by the mitochondrial insults (Extended Data Fig. 4a ) and because these molecules are localized to the site of injury (Fig. 4d ). Ceramides are upstream elements of the stress response of plasma membrane, endoplasmic reticulum and mitochondria in multiple species 19, 20 , and can act as hormonal signals 21 . But it is also possible that these constitute membrane elements required for other signals. Variations in the animal pathways for mitochondrial surveillance identified here, many of which involve conserved proteins, may underlie variation in the symptoms caused by the same mitochondrial mutations or variation in response to mitochondrial toxins such as statins. Microbial secondary metabolites that render animals unresponsive to their mitochondrial dysfunctions ( Fig. 2d, e ) may have therapeutic potential in the treatment of a predicted upregulation of detoxification and antibacterial pathways, which may contribute to the devastating symptoms of some mitochondrial diseases. The anti-surveillance activities of such natural products may also treat other disorders of dysregulated detoxification and innate immunity, such as autoimmunity.
METHODS SUMMARY
RNAi clones in E. coli were seeded to 24-well worm plates and ,40 worms per well were assayed at 48 h. For drug screens, GFP expression was assayed after 24 h. Wild microbes were seeded onto 24-well plates in duplicate and ,40 synchronized L1 worms were added to the wells. Animals were scored after 48 h.
Online Content Any additional Methods, Extended Data display items and Source Data are available in the online version of the paper; references unique to these sections appear only in the online paper. LETTER RESEARCH METHODS C. elegans strains. hsp-6p::gfp(zcIs13)V, dpy-5(e907)I;ugt-61p::gfp(sEX11571), hsp-4p::gfp (zcIs4)V, myo-3p::GFPmt(zcIs14), isp-1(qm150), sptl-1(ok1693)II, tag-38(ok490)V, lagr-1(gk327)I;hyl-1(ok976)IV, sphk-1(ok1097)II, hyl-2(ok1766)X, hyl-2(gnv1)X and asm-3(ok1744)IV were obtained from the Caenorhabditis Genetics Center (CGC). irg-1p::gfp was provided by F. Ausubel. isp-1;hsp-6p::gfp was generated by crossing hsp-6p::gfp into isp-1(qm150). atfs-1;hsp-60p::gfp, atfs-1(tm4525);hsp-16p::atfs-1 D1-32.myc ::gfp and atfs-1(tm4525);hsp-16p::atfs-1 D1-32.myc ;hsp-60p::gfp were provided by C. Haynes. Hermaphrodites were used throughout the study. Activation of GFP reporter by wild microbes. Wild microbes isolated from various habitats harbouring wild C. elegans populations 10 (B.S.S., M.A. Félix & G.R., unpublished observations) were grown in LB at 18 uC shaking for 16-18 h, concentrated 33 and seeded (30 ml) into 24-well NGM plates (no antibiotics) in duplicate. Plates were dried and allowed to grow overnight at room temperature (,22 uC) before ,40 synchronized L1 worms were added to the wells. Animals were scored after 48 h at 20 uC. Genera with more than three independent isolates that induced hsp-6p::gfp expression are noted along with the percentage of total microbes tested ( Fig. 2a ). Other genera that strongly activate hsp-6p::gfp expression include Achromobacter, Curtobacterium, Enterobacter, Leucobacter, Mycetocola, Myroides, Raoultella and Rhodococcus. Activation of GFP reporter by RNAi. RNAi clones were grown in LB containing 50 mg ml 21 carbenicillin at 37 uC overnight and seeded 100 ml per well to 24-well worm plates with 5 mM IPTG. Dried plates were kept at room temperature overnight to allow IPTG induction of double-stranded RNA (dsRNA) expression. Synchronized L1 worms (,40 worms per well) were raised on the RNAi plate at 20 uC. Fluorescence was assayed at 48 h. Activation of GFP reporter by drugs. Synchronized L1 worms (,40 worms per well) were raised on a 24-well plate at 20 uC for 48 h. At this time, each well was treated with 0.5 mg antimycin (total volume 20 ml) in M9 buffer (3 g KH 2 PO 4 , 6 g Na 2 HPO 4 , 5 g NaCl, 1 ml 1 M MgSO 4 , H 2 O to 1 litre), or 1.5 mg tunicamycin in DMSO (total volume 20 ml). GFP expression was assayed after 24 h (antimycin), or 7 h (tunicamycin). Microscopy. Comparable GFP reporter images were obtained by a Zeiss AxioImager Z1 using the same exposure time. Mitochondrial morphology of C. elegans or HEK293T cells was visualized under an Olympus Fluoview 1000 confocal microscope.
Genome-wide RNAi screen. Primary screen was performed by seeding individual bacterial clones each bearing a distinct C. elegans dsRNA to initiate RNAi onto 24well RNAi plates. Dried plates were kept at room temperature overnight to induce the expression of dsRNAs. Synchronized L1 hsp-6p::gfp worms (,40 animals per well) were raised on the 24-well plate at 20 uC for 48 h. At this time, each well was treated with 0.5 mg antimycin in M9 buffer (total volume 20 ml). GFP expression was assayed after 24 h. Scores were recorded from 0 (no inhibition of GFP expression) to 4 (strong inhibition of GFP expression). Positive clones from the primary screen were picked and re-screened in multiple parallel secondary screens. For one screen, synchronized L1 hsp-6p::gfp worms (,40 animals per well) were raised on 24-well plates at 20 uC for 36 h. At this time, each well was treated with 20-fold concentrated E. coli expressing atp-2 dsRNA (total volume 20 ml), to inactivate the mitochondria using RNAi rather than using the antimycin of the primary screen. GFP expression was assayed after 36 h. In a third test, synchronized L1 isp-1(qm150);hsp-6p::gfp (2 animals per well) were dropped onto a 24-well plate using a worm sorter, and raised at 20 uC. This strain carries a mitochondrial mutation that activates hsp-6p::gfp expression in untreated animals as well as in most wells. Fluorescence was scored when they reached the L4 stage and again when their progeny (if the strains were fertile) developed to the L4 stage.
In a fourth parallel screen, synchronized L1 ugt-61p::gfp worms (,40 animals per well) were raised on 24-well plate at 20 uC for 48 h. At this time, each well was treated with 0.5 mg antimycin in M9 (total volume 20ul). GFP expression was assayed after 24 h. Western blotting. Synchronized worms were raised on plates under the described conditions. Worms were then washed off plates, re-suspended with NuPAGE LDS Sample Buffer (Invitrogen) and boiled at 95 uC for 5 min. Lysates containing the same amount of protein were loaded onto SDS-PAGE and transferred onto Nitrocellulose membrane (Invitrogen). After being blocked with 5% nonfat milk, the membrane was probed with the designated first and second antibodies and developed with the enhanced chemiluminescence method (Perkin Elmer) and visualized by X-ray film. RNA isolation and real-time PCR. Synchronized L1 wild-type N2 and mutant worms were raised on control or spg-7(RNAi) at 20 uC, and collected at the L4 stage. Worms were then washed, re-suspended with TRIzol reagent (Invitrogen), frozen and homogenized by grinding. Total RNA was isolated by chloroform extraction, followed by ethanol precipitation and DNase treatment (Ambion, Turbo DNA free kit). Complementary DNA was then synthesized by reverse transcription (Invitrogen, SuperScript III First-Strand Synthesis System). Real-time PCR was carried out using SYBR GREEN PCR Master Mix (Bio-Rad). Quantification of transcripts was normalized to rpl-32 and relative expression levels were calculated as described previously 22 . Food-avoidance assays. Each gene inactivation that disrupted the response to mitochondrial dysfunction was grown in 1 ml LB containing 50 mg ml 21 carbenicillin at 37 uC overnight, pelleted, re-suspended with 50 ml LB and dropped in the centre of a well of 6-well plates containing 5 mM IPTG. Dried plates were kept at room temperature overnight to allow IPTG induction of dsRNA expression. Only circular lawns of uniform size and density were used for food-avoidance assays. Synchronized L1 worms (,100 animals per well) were dropped into the centre of each bacterial lawn. Food-avoidance phenotypes were scored at 48 h. For antimycin treatment, synchronized L1 worms (,100 animals per well) were dropped into the centre of each bacterial lawn, and grown at 20 uC for 48 h. At this time, 50 mg antimycin (total volume 80 ml) was added directly to the bacteria lawn. Food avoidance was scored 8 h after drug treatment. Synthetic growth defect on sptl-1(RNAi). Wild-type N2 or mitochondrial mutant allele isp-1 animals were synchronized at the L1 stage. Animals were then raised on control or sptl-1(RNAi). isp-1 animals were grown on control RNAi for 3 days versus on sptl-1(RNAi) for 5 days to match the developmental stage of wild-type N2 animals. Ceramide biosynthetic mutant analyses. To dissect the pathway of sptl-1 function in mitochondrial surveillance, we tested other mutations in the sphingolipid biosynthetic pathway (Extended Data Figs 4 and 5a ). Inactivation of another serine palmitoyltransferase gene sptl-3 had no effect on the induction of hsp-6 upon mitochondrial damage (Extended Data Figs 4, 5a, b) . A double mutation of hyl-1 and lagr-1, which encode ceramide synthases, reduced the induction of hsp-6 upon mitochondrial damage (Extended Data Fig. 5b ), whereas hyl-1 or lagr-1 single mutants were less defective (Extended Data Fig. 5c ). Only the C24 ceramide, synthesized by HYL-1, rescued the deficiency of mitochondrial surveillance caused by sptl-1(RNAi). This is consistent with the defect in hsp-6 induction shown in the hyl-1;lagr-1 double mutant (Extended Data Fig. 5b) .
Immunostaining. Immunostaining of dissected animals was carried out according to ref. 23 with minor modifications. Specifically, dissected animals were blocked with 0.5% BSA in PBST for 1 h at room temperature, and stained with anti-ceramide antibody (MID15B4, Alexis Biochemicals, diluted 1:60 (v/v)) in 0.2% BSA in PBST and anti-human OxPhos Complex IV antibody (Invitrogen diluted 1:30 (v/v)) at room temperature for 30 min and 4 uC overnight. These were then washed three times with PBST (10 min each time) and slides were then incubated with Cy-3 antimouse secondary antibody (diluted 1:200 (v/v)) for 1 h at room temperature. After three further washes with PBST (10 min each time), slides were mounted and visualized under an Olympus Fluoview 1000 confocal microscope.
HEK293T cells (ATCC) were washed twice with ice cold PBS and fixed with 4% formaldehyde at 4uC for 1 h. After fixation, cells were permeabilized by 0.1% Triton in PBS at room temperature for 8 min, and then blocked with 0.5% BSA in PBST for 1 h at room temperature, and stained with anti-human OxPhos Complex IV antibody (Invitrogen diluted 1:30 (v/v)) at room temperature for half hour and 4uC overnight. Following three washes with PBST (10 min each time), slides were mounted and visualized under an Olympus Fluoview 1000 confocal microscope. ATP levels. C2C12 myoblasts (ATCC) were grown in DMEM supplemented with 10% (v/v) FBS and antibiotics (100 mg ml 21 penicillin/streptomycin mix) at 37 uC. Differentiation into myotubes was induced at ,90% density by changing the medium to DMEM supplemented with 2% (v/v) horse serum. Differentiation occurred after 5 days. Myotubes were then treated with DMSO, 10 mM simvastatin or 10 mM mevastatin. After incubation for 48 h, CellTiter-Glo reagent (Promega) was added to cell-culture medium, and luminescence was measured after 10 min incubation. Primers for quantitative RT-PCR. hsp-6: forward CAAACTCCTGTGTCAGT ATCATGGAAGG, reverse GCTGGCTTTGACAATCTTGTATGGAACG; cyp-14A3: forward CAGTTTCCCGCCGAAAACATCCATTTG, reverse CAATGCC GTTCTTCTTTGAAGCCTCCAG; ugt-61: forward GCAATTGGAGGTCATG ACGTAACTATG, reverse GCGAAGAATGATTCGGCATCCATCTTG; rpl-32: forward AGGGAATTGATAACCGTGTCCGCA, reverse TGTAGGACTGCAT GAGGAGCATGT; sptl-1: forward CTGAAAGGCAGAAAGATGAATTAATTGC, reverse GAATCCACGTGGCCCGCACGATCCTACG. Primers for genotyping. sptl-1: forward AGCCCAAGCCAATTATCCTT, reverse AACACGAACTTTGAATCGCC; sptl-3: forward CTTGGTGTCCCTTTCGTG TT, reverse AGGGCAAGAATTGGGGTAAT; F27E5.1: forward TGAAAGACA ACTTGCTCGGA, reverse TGTCTTTTCAGCAGTCACCG; T10B11.2: forward TCATTCCGACGGTACCATTT, reverse TGAAGCTTGAAATGCAGTGG; asm-3: forward CTTGCACTCCTCCTTTCCAC, reverse GGTGACAGAATGCGAGGA AT; hyl-1: forward GCCCCGTAAATAAGCACAAA, reverse TCGTGTTCTTTC ACGTCTCG; hyl-2: forward GGGGGAGTGATGGAAGAAAT, reverse TTGCA AACCAATTGCAAGAA; lagr-1: forward ATGCTTGGACCTGAATAC, reverse LETTER RESEARCH
